MIRAGEN THERAPEUTICS, INC. Business Finance Contracts & Agreements
38 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Exchange Agreements (2)
- Guaranty Agreements (1)
- Loan Agreements (4)
- Note Agreements (2)
- Purchase Agreements (3)
- Registration Rights Agreements (4)
- Stock Agreements (5)
- Subscription Agreements (3)
- Underwriting Agreements (7)
- Warrant Agreements (5)
- 2016 Amended and Restated Employee Stock Purchase Plan (Filed With SEC on February 27, 2024)
- Underwriting Agreement, by and among the Company and the Representatives, dated as of January 17, 2024 (Filed With SEC on January 19, 2024)
- Registration Rights Agreement, dated October 30, 2023, by and between the Company and the Purchasers signatory thereto (Filed With SEC on October 30, 2023)
- Securities Purchase Agreement, dated October 30, 2023, by and between the Company and the Purchasers signatory thereto (Filed With SEC on October 30, 2023)
- Underwriting Agreement by and among the Company and the Representatives, dated as of August 16, 2022 (Filed With SEC on August 19, 2022)
- Loan and Security Agreement, dated as of April 1, 2022, among Viridian Therapeutics, Inc., certain of its subsidiaries from time to time party thereto, the Lenders from time to... (Filed With SEC on April 5, 2022)
- Subscription Agreement, by and between the Registrant and Xencor, dated as of December 2, 2021 (Filed With SEC on March 11, 2022)
- Underwriting Agreement by and among the Company and the Representatives, dated as of September 20, 2021 (Filed With SEC on September 23, 2021)
- Subscription Agreement, by and between the Registrant and Xencor, Inc., dated as of December 16, 2020 (Filed With SEC on March 26, 2021)
- Registration Rights Agreement, dated as of October 30, 2020, by and among the Registrant and certain purchasers (Filed With SEC on November 12, 2020)
- Form of Registration Rights Agreement, by and among Miragen Therapeutics, Inc. and certain purchasers (Filed With SEC on October 28, 2020)
- Securities Purchase Agreement, dated as of October 27, 2020, by and among Miragen Therapeutics, Inc. and each purchaser identified on Annex A thereto (Filed With SEC on October 28, 2020)
- U.S. Small Business Administration Paycheck Protection Program Note, by and between Miragen Therapeutics, Inc. and Silicon Valley Bank, dated April 21, 2020 (Filed With SEC on April 27, 2020)
- Form of Warrant to Purchase Common Stock (Filed With SEC on February 7, 2020)
- Underwriting Agreement, dated February 7, 2020, by and among Miragen Therapeutics, Inc. and Oppenheimer & Co. Inc (Filed With SEC on February 7, 2020)
- Common Stock Purchase Agreement, dated December 11, 2019 between Miragen Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on December 11, 2019)
- Registration Rights Agreement, dated December 11, 2019, between Miragen Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on December 11, 2019)
- Assignment and Assumption Agreement, dated as of October 28, 2019, by and between the Registrant, The Leukemia & Lymphoma Society, Inc. and LLS TAP Miragen, LLC (Filed With SEC on October 31, 2019)
- Common Stock Purchase Agreement, dated August 6, 2018, by and between the Registrant and The Leukemia & Lymphoma Society, Inc (Filed With SEC on November 7, 2018)
- Warrant to Purchase Stock between Miragen Therapeutics, Inc. and Silicon Valley Bank, dated April 30, 2015 (Filed With SEC on March 15, 2018)
- Underwriting Agreement, dated February 8, 2018, by and among Miragen Therapeutics, Inc. and Jefferies LLC, Evercore Group L.L.C. and Deutsche Bank Securities Inc (Filed With SEC on February 9, 2018)
- Warrant to Purchase Stock between Miragen Therapeutics, Inc. and Silicon Valley Bank, dated November 14, 2017 (Filed With SEC on November 15, 2017)
- Amended and Restated Loan and Security Agreement between Miragen Therapeutics, Inc. and Silicon Valley Bank, dated November 14, 2017 (Filed With SEC on November 15, 2017)
- MIRAGEN THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENT (Filed With SEC on March 31, 2017)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on December 2, 2016)
- SUBSCRIPTION AGREEMENT (Filed With SEC on December 2, 2016)
- INTELLECTUAL PROPERTY PURCHASE AGREEMENT (Filed With SEC on December 1, 2016)
- SIGNAL GENETICS, INC. AMENDMENT TO UNSECURED DEMAND PROMISSORY NOTE (Filed With SEC on November 1, 2016)
- SIGNAL GENETICS, INC.By:/s/ Bennett S. LeBow Bennett S. LeBowChairman of the Board of DirectorsAcknowledged: /s/ Samuel D. Riccitelli Samuel D. Riccitelli [Signature page to... (Filed With SEC on March 27, 2015)
- Form of Representative’s Warrant Agreement (Filed With SEC on January 29, 2015)
- UNDERWRITING AGREEMENT between SIGNAL GENETICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on January 29, 2015)
- EXCHANGE AGREEMENT (Filed With SEC on August 14, 2014)
- Form of Representative’s Warrant Agreement (Filed With SEC on June 6, 2014)
- EXCHANGE AGREEMENT (Filed With SEC on April 9, 2014)
- GUARANTY AND SECURITY AGREEMENT Dated as of November 3, 2011 among SIGNAL GENETICS, LLC, MYELOMA HEALTH LLC, RESPIRA HEALTH LLC and CC HEALTH LLC, as the Borrowers, and Each Other... (Filed With SEC on March 19, 2014)
- ASSIGNMENT OF MEMBERSHIP INTERESTS (Filed With SEC on March 19, 2014)
- UNDERWRITING AGREEMENT between SIGNAL GENETICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters (Filed With SEC on March 19, 2014)
- First Amendment to Loan and Security Agreement, dated as of August 7, 2023, among the Viridian Therapeutics, Inc., certain of its subsidiaries from time to time party thereto, the... (Filed With SEC on November 13, 2023)
